SPY443.91+0.73 0.16%
DIA347.87+0.31 0.09%
IXIC15,047.70-4.55 -0.03%

BRIEF-Axogen Recon(SM) Clinical Study Completes Subject Follow-Up

reuters.com · 09/01/2021 07:25
BRIEF-Axogen Recon(SM) Clinical Study Completes Subject Follow-Up

- AxoGen Inc AXGN:

  • AXOGEN RECON(SM) CLINICAL STUDY COMPLETES SUBJECT FOLLOW-UP

  • AXOGEN INC - STUDY REMAINS ON SCHEDULE WITH A TOP LINE STUDY DATA READ-OUT EXPECTED IN Q2 OF 2022, FOLLOWED BY FILING OF BLA SUBMISSION IN 2023

Source text for Eikon: ID:nGNX3FxdPC

Further company coverage: AXGN


((Reuters.Briefs@thomsonreuters.com;))